Found 206 hits Enz. Inhib. hit(s) with all data for entry = 1564 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Apolipoprotein L1
(Homo sapiens) | BDBM615196
(3-[2-(4-cyanophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-h...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(cc1)C#N |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615197
(US20230271945, Compound 117)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(OC(F)F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615198
(US20230271945, Compound 118)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(OC(F)(F)F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615198
(US20230271945, Compound 118)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(OC(F)(F)F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615200
(US20230271945, Compound 120)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(Cl)c(F)c1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615200
(US20230271945, Compound 120)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(Cl)c(F)c1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547880
(CHEMBL4789274 | US20230271945, Compound 121)Show SMILES COc1ccc(cc1)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547880
(CHEMBL4789274 | US20230271945, Compound 121)Show SMILES COc1ccc(cc1)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615202
(US20230271945, Compound 122)Show SMILES Cc1ccc(-c2[nH]c3ccccc3c2CCC(=O)N[C@H]2[C@H](O)CNC2=O)c(F)c1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615202
(US20230271945, Compound 122)Show SMILES Cc1ccc(-c2[nH]c3ccccc3c2CCC(=O)N[C@H]2[C@H](O)CNC2=O)c(F)c1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615203
(US20230271945, Compound 123)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(cc1)C(F)(F)F |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615203
(US20230271945, Compound 123)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(cc1)C(F)(F)F |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615204
(US20230271945, Compound 124)Show SMILES Cc1ccc(cc1)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615204
(US20230271945, Compound 124)Show SMILES Cc1ccc(cc1)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615205
(US20230271945, Compound 125)Show SMILES Cc1cc(ccc1F)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615205
(US20230271945, Compound 125)Show SMILES Cc1cc(ccc1F)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615206
(US20230271945, Compound 126)Show SMILES Cc1ccc(cc1F)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615206
(US20230271945, Compound 126)Show SMILES Cc1ccc(cc1F)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615208
(3-[2-(4-chlorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(Cl)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615208
(3-[2-(4-chlorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(Cl)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615209
(3-[2-(3,4-difluorophenyl)-1H-indol-3-yl]-N-[(3S,4R...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(F)c(F)c1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615209
(3-[2-(3,4-difluorophenyl)-1H-indol-3-yl]-N-[(3S,4R...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(F)c(F)c1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615210
(2-[[2-(4-fluorophenyl)-1H-indol-3-yl]sulfanyl]-N-[...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CSc1c([nH]c2ccccc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615124
(3-[2-(4-bromophenyl)-5-methyl-1H-indol-3-yl]-N-[(3...)Show SMILES Cc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(Br)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615124
(3-[2-(4-bromophenyl)-5-methyl-1H-indol-3-yl]-N-[(3...)Show SMILES Cc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(Br)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615125
(3-(5-chloro-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-h...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(Cl)cc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615125
(3-(5-chloro-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-h...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(Cl)cc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615126
(3-[5-chloro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(Cl)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615127
(US20230271945, Compound 46)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615127
(US20230271945, Compound 46)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615128
(US20230271945, Compound 47)Show SMILES Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615128
(US20230271945, Compound 47)Show SMILES Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615129
(US20230271945, Compound 48)Show SMILES Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)NC1CCNC1=O |w:21.24| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615129
(US20230271945, Compound 48)Show SMILES Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)NC1CCNC1=O |w:21.24| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615132
(US20230271945, Compound 51)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615132
(US20230271945, Compound 51)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615133
(US20230271945, Compound 52)Show SMILES Fc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615133
(US20230271945, Compound 52)Show SMILES Fc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615139
(US20230271945, Compound 58)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)c(F)ccc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615139
(US20230271945, Compound 58)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)c(F)ccc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615140
(US20230271945, Compound 59)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)c(F)ccc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615140
(US20230271945, Compound 59)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)c(F)ccc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547878
(CHEMBL4752052 | US20230271945, Compound 61)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cccc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547878
(CHEMBL4752052 | US20230271945, Compound 61)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cccc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615143
(N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]-3-(2-p...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(C=C)cccc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615144
(US20230271945, Compound 63)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cccc12)C1CC1)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615150
(US20230271945, Compound 69)Show SMILES Cc1cccc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615151
(US20230271945, Compound 70)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Br)cccc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615151
(US20230271945, Compound 70)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Br)cccc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615152
(US20230271945, Compound 71)Show SMILES Cc1cccc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Search and Browse
